この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2009/7/221 分で読めます
Withdrawal of Approval of New Animal Drug Applications; Ketamine; S-Methoprene; Nitazoxanide
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADAs) and an abbreviated new animal drug application (ANADA) listed in table 1 of this document. In a final rule published elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to remove portions reflecting approval of these NADAs and ANADA.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →